Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Neurokinin B is a Preferred Agonist for a Neuronal Substance P Receptor and Its Action is Antagonized by Enkephalin

Ralph Laufer, Uri Wormser, Zeev Y. Friedman, Chaim Gilon, Michael Chorev and Zvi Selinger
Proceedings of the National Academy of Sciences of the United States of America
Vol. 82, No. 21 (Nov. 1, 1985), pp. 7444-7448
Stable URL: http://www.jstor.org/stable/26387
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Neurokinin B is a Preferred Agonist for a Neuronal Substance P Receptor and Its Action is Antagonized by Enkephalin
Preview not available

Abstract

Receptor specificity of the substance P-related peptides neurokinin A and neurokinin B was studied in the isolated guinea pig ileum. Substance P and the recently discovered neurokinins elicit contraction of the ileum both directly through action on a muscle cell receptor and indirectly through stimulation of a neuronal receptor, leading to release of acetylcholine, which causes muscle contraction via muscarinic receptors. Two specific assay procedures for the function of the neuronal receptor were developed. The muscular receptor was inactivated either by desensitization with the selective agonist substance P methyl ester or by receptor blockade with the selective antagonist [Arg6, D-Trp7,9, Me-Phe8]substance P-(6-11) hexapeptide. Both procedures revealed that the neuronal receptor is clearly distinct from the muscular receptor, since it exhibits different agonist specificity and is insensitive to antagonists of the muscular receptor. Neurokinin B was found to be the most potent agonist (EC50 = 1 nM) for the neuronal receptor. Furthermore, [D-Ala2, Met5]enkephalinamide inhibited in a naloxone-sensitive manner the effect of neurokinin B mediated via the neuronal receptor. These results suggest that the different mammalian tachykinins can play specific physiological roles by virtue of their distinct receptor specificities.

Page Thumbnails

  • Thumbnail: Page 
7444
    7444
  • Thumbnail: Page 
7445
    7445
  • Thumbnail: Page 
7446
    7446
  • Thumbnail: Page 
7447
    7447
  • Thumbnail: Page 
7448
    7448